Portfolio company
RNAnalytics
Austria
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
SourceFunding history · 1
Similar companies
Adalid Science
Adalid Sciences develops lipid nanoparticle delivery systems for nucleic acid therapeutics, serving pharmaceutical companies, biotechnology start-ups, and contract development and manufacturing organisations.
Breeze
This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.
Nanolyze AB
This company develops optical waveguide instruments for label-free nanoparticle analysis, providing researchers with tools to study nanomedicines and biological particles in real time.
Fida Biosystems
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
AtomBioworks
This company develops artificial intelligence software for designing nucleic acids, including mRNA and aptamers, for biotechnology firms and medical research organisations.
Argonaute RNA
This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.
Terrain Bio
This company provides machine learning software and manufacturing services for RNA therapeutic sequences to biopharmaceutical research teams.
